Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (42)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Argilés, A.
Right arrow Articles by Demaille, J.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Argilés, A.
Right arrow Articles by Demaille, J.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1994) 9: 662-667
© 1994 European Renal Association-European Dialysis and Transplant Association


research-article

Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages

A. Argilés1, G. Mourad2,3, P.G. Kerr3, M. García1, B. Collins2 and J.G. Demaille1

1UPR 9008 CNRS/CRBM, Faculté de Medecine, Université de Montpellier I Montpellier, France 2Department of Pathology, Massachusetts General Hospital Boston, USA 3Department of Nephrology, Monash Medical Centre Clayton, Australia 4Department of Nephrology, University Hôpital Montpellier

Dialysis-related amyloidosis is a type of amyloidosis which has ß2-microglobulin as the major protein constituent and occurs predominantly in haemodialysis patients. Its prevalence is very high with increasing time on dialysis treatment and its pathogenesis is not completely understood. While remarkable progress has been made in the identification of the components of the deposits, there are no reports characterizing the cells surrounding the amyloid fibrils. To characterize the cellular composition of the amyloid material, specimens from seven patients treated by maintenance haemodialysis were studied with immunoperoxidase labelling using monoclonal antibodies to leukocytes (CD3, CD14, CD68, CD4, CD8, CD45). The results were very reproducible for the seven deposits assessed: Of the 182 ± 26 leukocytes/0.2 mm2 of amyloid tissue expressing the 71.5–CD45 marker (common leukocyte), 91± 6 % were CD68 (KP1) positive (monocyte macrophage). No CD3-positive cells (T-cell marker) were found in six of the seven patients, with only 1.6% in the remaining one.

The present study shows that although amyloidosis has classically been considered as an acellular pathology, clearly there are cells surrounding amyloid fibrils. Strikingly, these cells are almost exclusively macrophages; there are no lymphocytes or granulocytes. The putative role of macrophages in the pathogenesis of ß2-microglobulin amyloidosis remains to be established. However, the identification and quantitation of the cells surrounding the amyloid deposits may be important for subsequent studies to elucidate amyloid pathogenesis and particularly protein–cell interactions.

Keywords: amyloid deposits; haemodialysis; macrophages; dialysis related amyloidosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. J. Morten, W. S. Gosal, S. E. Radford, and E. W. Hewitt
Investigation into the Role of Macrophages in the Formation and Degradation of beta2-Microglobulin Amyloid Fibrils
J. Biol. Chem., October 5, 2007; 282(40): 29691 - 29700.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. D. O'Neill, N. X. Chen, M. Wang, R. Cocklin, Y. Zhang, and S. M. Moe
Cellular uptake of {beta}2M and AGE-{beta}2M in synovial fibroblasts and macrophages
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 46 - 53.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Garcia-Garcia, G. Mourad, M. Durfort, J. Garcia-Valero, and A. Argiles
Vascular involvement and cell damage in experimental AA and clinical {beta}2-microglobulin amyloidosis
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1450 - 1456.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. F. Hou, J. P. Jiang, J. Q. Guo, G. B. Wang, X. Zhang, D. M. Stern, A. M. Schmidt, and W. F. Owen Jr.
Receptor for Advanced Glycation End Products on Human Synovial Fibroblasts: Role in the Pathogenesis of Dialysis-Related Amyloidosis
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1296 - 1306.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.